Literature DB >> 25123177

The pathologic correlation between liver and portal vein invasion in perihilar cholangiocarcinoma: evaluating the oncologic rationale for the American Joint Committee on Cancer definitions of T2 and T3 tumors.

Takaaki Ito1, Tomoki Ebata, Yukihiro Yokoyama, Tsuyoshi Igami, Gen Sugawara, Takashi Mizuno, Yoshie Shimoyama, Masato Nagino.   

Abstract

BACKGROUND: The American Joint Committee on Cancer (AJCC) has recommended that cancers with liver involvement be graded T2b and those with portal vein involvement be graded T3, although the value of staging as prognostic factors remains unclear. We evaluated the current definition of the T2/3 tumors for perihilar cholangiocarcinoma.
METHODS: A total of 202 patients with perihilar cholangiocarcinoma who underwent hepatectomy without vascular resection were enrolled. Clinicopathologic data about invasion of the liver and the unilateral portal vein were evaluated.
RESULTS: The liver and the unilateral portal vein were involved in 100 (49.5 %) and 38 (18.8 %) patients, respectively. The survival rates were not significantly different between patients with and without liver invasion (48.6 vs. 52.2 %, respectively, at 5 years, P = 0.157) and between patients with or without unilateral portal vein invasion (43.2 vs. 52.1 %, respectively, at 5 years, P = 0.363). The survival rate of patients with tumors staged pT2b was not significantly different from the rate of patients with pT2a (63.4 vs. 55.6 % at 5 years, P = 0.912), and the pT2b tumor patient survival rate was better than the rate of patients with pT3 (34.9 % at 5 years, P = 0.011). Using multivariate analysis, nodal metastasis (P = 0.003), positive surgical margin (P = 0.010), and Bismuth type IV tumor (P = 0.039) were identified as independent prognostic factors.
CONCLUSIONS: The liver and the unilateral portal vein are frequently involved in perihilar cholangiocarcinoma. The determinants of the current AJCC T2/3 tumor classifications are rational; however, subdivision of T2 tumors may be of less clinical value.

Entities:  

Mesh:

Year:  2014        PMID: 25123177     DOI: 10.1007/s00268-014-2719-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

Review 1.  Anatomy of the hepatic hilar area: the plate system.

Authors:  Y Kawarada; B C Das; H Taoka
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

2.  Connective tissue configuration in the human liver hilar region with special reference to the liver capsule and vascular sheath.

Authors:  Shogo Hayashi; Gen Murakami; Aiji Ohtsuka; Masahiro Itoh; Takashi Nakano; Yoshitaka Fukuzawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-11-07

3.  New staging system and a registry for perihilar cholangiocarcinoma.

Authors:  Michelle L Deoliveira; Richard D Schulick; Yuji Nimura; Charles Rosen; Gregory Gores; Peter Neuhaus; Pierre-Alain Clavien
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

4.  The concept of perihilar cholangiocarcinoma is valid.

Authors:  T Ebata; J Kamiya; H Nishio; T Nagasaka; Y Nimura; M Nagino
Journal:  Br J Surg       Date:  2009-08       Impact factor: 6.939

5.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

6.  The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients.

Authors:  Kenichi Matsuo; Flavio G Rocha; Kaori Ito; Michael I D'Angelica; Peter J Allen; Yuman Fong; Ronald P Dematteo; Mithat Gonen; Itaru Endo; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2012-06-28       Impact factor: 6.113

7.  Spread of hilar cholangiocarcinomas via peribiliary gland network: a hither-to-unrecognized route of periductal infiltration.

Authors:  Hirohide Sato; Yasuni Nakanuma; Kazuto Kozaka; Yasunori Sato; Hiroko Ikeda
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

Review 8.  Hilar cholangiocarcinoma: current management.

Authors:  Fumito Ito; Clifford S Cho; Layton F Rikkers; Sharon M Weber
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

9.  Intraductal oncocytic papillary neoplasm of the bile duct: the first case of peribiliary gland origin.

Authors:  Yoshitsugu Nakanishi; Yoh Zen; Satoshi Hirano; Eiichi Tanaka; Osamu Takahashi; Atsuya Yonemori; Hiromitsu Doumen; Hiroshi Kawakami; Tomoo Itoh; Yasuni Nakanuma; Satoshi Kondo
Journal:  J Hepatobiliary Pancreat Surg       Date:  2009-03-26

10.  Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas.

Authors:  T Ebata; T Kosuge; S Hirano; M Unno; M Yamamoto; M Miyazaki; N Kokudo; S Miyagawa; T Takada; M Nagino
Journal:  Br J Surg       Date:  2014-01       Impact factor: 6.939

View more
  7 in total

1.  Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resection.

Authors:  Víctor Molina; Jaime Sampson; Joana Ferrer; Alba Díaz; Juan Ramon Ayuso; Santiago Sánchez-Cabús; Josep Fuster; Juan Carlos García-Valdecasas
Journal:  Langenbecks Arch Surg       Date:  2016-12-23       Impact factor: 3.445

Review 2.  Current Status on Cholangiocarcinoma and Gallbladder Cancer.

Authors:  Tomoki Ebata; Giorgio Ercolani; Domenico Alvaro; Dario Ribero; Luca Di Tommaso; Juan W Valle
Journal:  Liver Cancer       Date:  2016-11-29       Impact factor: 11.740

3.  External validation study of the 8th edition of the American Joint Committee on Cancer staging system for perihilar cholangiocarcinoma: a single-center experience in China and proposal for simplification.

Authors:  Jian Zhao; Wei Zhang; Jun Zhang; Wen-Jie Ma; Si-Yun Liu; Fu-Yu Li; Bin Song
Journal:  J Gastrointest Oncol       Date:  2021-04

4.  Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.

Authors:  Jian Zhao; Wei Zhang; Jun Zhang; Yi Zhang; Wen-Jie Ma; Si-Yun Liu; Fu-Yu Li; Bin Song
Journal:  BMC Cancer       Date:  2020-09-03       Impact factor: 4.430

5.  Trends of the Extra-Hepatic Biliary Cancer and Its Surgical Management: A Cross-Sectional Study From the National Cancer Database.

Authors:  Faiz Tuma; Ali Abbaszadeh-Kasbi; Gitonga Munene; Saad Shebrain; William C Durchholz
Journal:  Cureus       Date:  2022-08-01

6.  Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker for Oncological Outcome in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma.

Authors:  Jan Bednarsch; Jakob Kather; Xiuxiang Tan; Shivan Sivakumar; Claudio Cacchi; Georg Wiltberger; Zoltan Czigany; Florian Ulmer; Ulf Peter Neumann; Lara Rosaline Heij
Journal:  Liver Cancer       Date:  2021-05-06       Impact factor: 11.740

7.  Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.

Authors:  Peizhan Chen; Bin Li; Yan Zhu; Wei Chen; Xin Liu; Mian Li; Xiaohua Duan; Bin Yi; Jinghan Wang; Chen Liu; Xiangji Luo; Xiaoguang Li; Jingquan Li; Lijian Liang; Xiaoyu Yin; Hui Wang; Xiaoqing Jiang
Journal:  Oncotarget       Date:  2016-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.